BENKOWITZ MICHAEL bought UTHR

September 8, 2025 · Form 4 insider transaction

BENKOWITZ MICHAEL bought 1,750 shares of United Therapeutics Corporation at $146.03 per share, a transaction worth $255.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,750
Price
$146.03
Total value
$255.6K
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 8, 2025
Filing dateSeptember 10, 2025
Shares owned after1,750
OwnershipIndirect
10b5-1 planYes
AmendedNo

Footnotes

This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025.; Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.

View the original Form 4 on SEC EDGAR